Diabetes, Vol 49, Issue 9 1485-1491, Copyright © 2000 by American Diabetes Association

ARTICLES

Glucose uptake, utilization, and signaling in GLUT2-null islets

MT Guillam, P Dupraz and B Thorens
Institute of Pharmacology and Toxicology, University of Lausanne, Switzerland.

We previously reported that pancreatic islet beta-cells from GLUT2-null mice lost the first phase but preserved the second phase of glucose-stimulated insulin secretion (GSIS). Furthermore, we showed that the remaining secretory activity required glucose uptake and metabolism because it can be blocked by inhibition of oxidative phosphorylation. Here, we extend these previous studies by analyzing, in GLUT2-null islets, glucose transporter isoforms and glucokinase expression and by measuring glucose usage, GSIS, and glucose-stimulated insulin mRNA biosynthesis. We show that in the absence of GLUT2, no compensatory expression of either GLUT1 or GLUT3 is observed and that glucokinase is expressed at normal levels. Glucose usage by isolated islets was increased between 1 and 6 mmol/l glucose but was not further increased between 6 and 20 mmol/l glucose. Parallel GSIS measurements showed that insulin secretion was not stimulated between 2.8 and 6 mmol/l glucose but was increased by >4-fold between 6 and 20 mmol/l glucose. Stimulation by glucose of total protein and insulin biosynthesis was also markedly impaired in the absence of GLUT2. Finally, we re-expressed GLUT2 in GLUT2-null beta-cells using recombinant lentiviruses and demonstrated a restoration of normal GSIS. Together, these data show that in the absence of GLUT2, glucose can still be taken up by beta-cells, albeit at a low rate, and that this transport activity is unlikely to be attributed to GLUT1 or GLUT3. This uptake activity, however, is limiting for normal glucose utilization and signaling to secretion and translation. These data further demonstrate the key role of GLUT2 in murine beta-cells for glucose signaling to insulin secretion and biosynthesis.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Roccisana, V. Reddy, R. C. Vasavada, J. A. Gonzalez-Pertusa, M. A. Magnuson, and A. Garcia-Ocana Targeted Inactivation of Hepatocyte Growth Factor Receptor c-met in {beta}-Cells Leads to Defective Insulin Secretion and GLUT-2 Downregulation Without Alteration of {beta}-Cell Mass Diabetes, July 1, 2005; 54(7): 2090 - 2102. [Abstract] [Full Text] [PDF]

				L Zhao, Z Li, M Kullin, L A H Borg, and F A Karlsson Alterations in net glucose uptake and in the pancreatic B-cell GLUT2 transporter induced by diazoxide and by secretory stimuli J. Endocrinol., May 1, 2005; 185(2): 291 - 299. [Abstract] [Full Text] [PDF]

				P. Bardoux, P. Zhang, D. Flamez, A. Perilhou, T. A. Lavin, J.-F. Tanti, K. Hellemans, E. Gomas, C. Godard, F. Andreelli, et al. Essential Role of Chicken Ovalbumin Upstream Promoter-Transcription Factor II in Insulin Secretion and Insulin Sensitivity Revealed by Conditional Gene Knockout Diabetes, May 1, 2005; 54(5): 1357 - 1363. [Abstract] [Full Text] [PDF]

				M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY Hyperinsulinism in Infancy: From Basic Science to Clinical Disease Physiol Rev, January 1, 2004; 84(1): 239 - 275. [Abstract] [Full Text] [PDF]

				N. Gorovits, L. Cui, J. V. Busik, M. Ranalletta, S. H. de-Mouzon, and M. J. Charron Regulation of Hepatic GLUT8 Expression in Normal and Diabetic Models Endocrinology, May 1, 2003; 144(5): 1703 - 1711. [Abstract] [Full Text] [PDF]

				J.-A. Haefliger, T. Tawadros, L. Meylan, S. L. Gurun, M.-E. Roehrich, D. Martin, B. Thorens, and G. Waeber The scaffold protein IB1/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic {beta} cells J. Cell Sci., April 15, 2003; 116(8): 1463 - 1469. [Abstract] [Full Text] [PDF]

				J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes Endocr. Rev., October 1, 2002; 23(5): 599 - 622. [Abstract] [Full Text] [PDF]

				C. G. Nichols and J. C. Koster Diabetes and insulin secretion: whither KATP? Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E403 - E412. [Abstract] [Full Text] [PDF]

				A. Shiroi, M. Yoshikawa, H. Yokota, H. Fukui, S. Ishizaka, K. Tatsumi, and Y. Takahashi Identification of Insulin-Producing Cells Derived from Embryonic Stem Cells by Zinc-Chelating Dithizone Stem Cells, July 1, 2002; 20(4): 284 - 292. [Abstract] [Full Text] [PDF]

				S. Kooptiwut, S. Zraika, A. W. Thorburn, M. E. Dunlop, R. Darwiche, T. W. Kay, J. Proietto, and S. Andrikopoulos Comparison of Insulin Secretory Function in Two Mouse Models with Different Susceptibility to {beta}-Cell Failure Endocrinology, June 1, 2002; 143(6): 2085 - 2092. [Abstract] [Full Text] [PDF]

				A. Garcia-Ocana, R. C. Vasavada, A. Cebrian, V. Reddy, K. K. Takane, J.-C. Lopez-Talavera, and A. F. Stewart Transgenic Overexpression of Hepatocyte Growth Factor in the {beta}-Cell Markedly Improves Islet Function and Islet Transplant Outcomes in Mice Diabetes, December 1, 2001; 50(12): 2752 - 2762. [Abstract] [Full Text] [PDF]

				C. Yang, T.-J. Chang, J.-C. Chang, M.-W. Liu, T.-Y. Tai, W. H. Hsu, and L.-M. Chuang Rosiglitazone (BRL 49653) Enhances Insulin Secretory Response via Phosphatidylinositol 3-Kinase Pathway Diabetes, November 1, 2001; 50(11): 2598 - 2602. [Abstract] [Full Text] [PDF]

				R. Burcelin and B. Thorens Evidence That Extrapancreatic GLUT2-Dependent Glucose Sensors Control Glucagon Secretion Diabetes, June 1, 2001; 50(6): 1282 - 1289. [Abstract] [Full Text]